A predictive model for neutropenia associated with cancer chemotherapyLYMAN, G. H.Pharmacotherapy. 2000, Vol 20, Num 7, pp 104S-111S, issn 0277-0008, 2Article

The effect of changing disease risk on clinical reasoningLYMAN, G. H; BALDUCCI, L.Journal of general internal medicine. 1994, Vol 9, Num 9, pp 488-495, issn 0884-8734Article

The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropeniaLYMAN, G. H; KUDERER, N. M.Critical reviews in oncology/hematology. 2004, Vol 50, Num 2, pp 129-146, issn 1040-8428, 18 p.Article

Basic population and cancer genetics and their use in the assessment of cancer riskLYMAN, G. H; KUDERER, N. M.European journal of cancer (1990). 1997, Vol 33, Num 13, pp 2160-2166, issn 0959-8049Article

Impact of smoking and smokeless tobacco on the risk of cancer of the head and neckSTOCKWELL, H. G; LYMAN, G. H.Head and neck surgery (New York, NY). 1986, Vol 9, Num 2, pp 104-110, issn 0148-6403Article

What threshold for adjuvant therapy in Older breast cancer patients?EXTERMANN, M; BALDUCCI, L; LYMAN, G. H et al.Journal of clinical oncology. 2000, Vol 18, Num 8, pp 1709-1717, issn 0732-183XArticle

The effects of NSAIDs on breast cancer prognostic factorsSCHAPIRA, D. V; THEODOSSIOU, C; LYMAN, G. H et al.Oncology reports. 1999, Vol 6, Num 2, pp 433-435, issn 1021-335XArticle

Methodological challenges in the evaluation of prognostic factors in breast cancerALTMAN, D. G; LYMAN, G. H.Breast cancer research and treatment. 1998, Vol 52, Num 1-3, pp 289-303, issn 0167-6806Article

Optimal duration of adjuvant tamoxifen treatment in elderly breast cancer patients: Influence of age, comorbidities, and various effectiveness hypotheses on life-expectancy and costEXTERMANN, M; BALDUCCI, L; LYMAN, G. H et al.Breast disease. 1996, Vol 9, Num 6, pp 327-339, issn 0888-6008Article

Lithium attenuation of leukopenia associated with cancer chemotherapyLYMAN, G. H; WILLIAMS, C. C.Lithium therapy monographs. 1991, Vol 4, pp 30-45, issn 1011-2928, 16 p.Article

Cancer in the elderly : Epidemiologic and clinical implicationsBALDUCCI, L; LYMAN, G. H.Clinics in geriatric medicine. 1997, Vol 13, Num 1, issn 0749-0690, vii, 1-14 [15 p.]Article

Continuous-infision diaziquone in acute myeloid leukemia: a southeastern cancer study group trialLYMAN, G. H; VOGLER, W. R; RANEY, M et al.Cancer treatment reports. 1987, Vol 71, Num 3, pp 309-310, issn 0361-5960Article

Association of leukemia with radium groundwater contaminationLYMAN, G. H; LYMAN, C. G; JOHNSON, W et al.JAMA, the journal of the American Medical Association. 1985, Vol 254, Num 5, pp 621-626, issn 0098-7484Article

Management of cancer in the agedBALDUCCI, L; LYMAN, G. H; FABRI, P. J et al.Comprehensive therapy. 1996, Vol 22, Num 2, pp 88-93, issn 0098-8243Article

Advances in current cancer treatment : an overviewLYMAN, G. H; SPIERS, A. S. D.Hematological oncology. 1992, Vol 10, Num 1, pp 3-6, issn 0278-0232Conference Paper

Cigarette smoking and the risk of female reproductive cancerSTOCKWELL, H. G; LYMAN, G. H.American journal of obstetrics and gynecology. 1987, Vol 157, Num 1, pp 35-40, issn 0002-9378Article

Timing of weight gain and breast cancer riskKUMAR, N. B; LYMAN, G. H; ALLEN, K et al.Cancer. 1995, Vol 76, Num 2, pp 243-249, issn 0008-543XArticle

Environmental tobacco smoke and lung cancer risk in nonsmoking womenSTOCKWELL, H. G; GOLDMAN, A. L; LYMAN, G. H et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 18, pp 1417-1422, issn 0027-8874Article

Risks associated with residence in the central Florida phosphate mining regionSTOCKWELL, H. G; LYMAN, G. H; WALTZ, J et al.American journal of epidemiology. 1988, Vol 128, Num 1, pp 78-84, issn 0002-9262Article

Major morbidity after pelvic exenteration: a seven-year experienceROBERTS, W. S; CAVANAGH, D; BRYSON, S. C. P et al.Obstetrics and gynecology (New York. 1953). 1987, Vol 69, Num 4, pp 617-621, issn 0029-7844Article

The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trialsLYMAN, G. H; DALE, D. C; CULAKOVA, E et al.Annals of oncology. 2013, Vol 24, Num 10, pp 2475-2484, issn 0923-7534, 10 p.Article

Evaluation and appraisal of randomized controlled trials in myelomaDJULBEGOVIC, B; ADAMS, J. R; LYMAN, G. H et al.Annals of oncology. 2001, Vol 12, Num 11, pp 1611-1617, issn 0923-7534Article

The economics of febrile neutropenia : Implications for the use of colony-stimulating factorsLYMAN, G. H; KUDERER, N; GREENE, J et al.European journal of cancer (1990). 1998, Vol 34, Num 12, pp 1857-1864, issn 0959-8049Article

High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myelomaBALLESTER, O. F; MOSCINSKI, L. C; LYMAN, G. H et al.Blood. 1994, Vol 83, Num 7, pp 1903-1908, issn 0006-4971Article

A new objective measurement of esophageal lumen patencyGOLDSCHMID, S; BOYCE, H. W. JR; BROWN, J. I et al.The American journal of gastroenterology. 1989, Vol 84, Num 10, pp 1255-1258, issn 0002-9270Article